Helicobacter pylori Biofilm Confers Antibiotic Tolerance in Part via A Protein-Dependent Mechanism

Helicobacter pylori, a WHO class I carcinogen, is one of the most successful human pathogens colonizing the stomach of over 4.4 billion of the world’s population. Antibiotic therapy represents the best solution but poor response rates have hampered the elimination of H. pylori. A growing body of evi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hathroubi, Skander, Zerebinski, Julia, Clarke, Aaron, Ottemann, Karen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345196/
https://www.ncbi.nlm.nih.gov/pubmed/32599828
http://dx.doi.org/10.3390/antibiotics9060355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345196/
https://www.ncbi.nlm.nih.gov/pubmed/32599828
http://dx.doi.org/10.3390/antibiotics9060355

Ejemplares similares